APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

NK Cells

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global NK Cells Industry Growth and Trends Forecast to 2032

Report ID 174017360122 December 2025109 pages

Choose your research edition.

Industry ResearchNK Cells Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal NK Cells Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal NK Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NK Cells Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal NK Cells Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global NK Cells market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NK Cells include Affimed NV, Altor BioScience, Chipscreen Biosciences, Fortress Biotech, Henry Ford Health Services, Innate Pharma, NantKwest, NKT and Sorrento Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global NK Cells market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The NK Cells market size, estimates, and forecasts are presented in terms of sales volume (g) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global NK Cells market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to NK Cells.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global NK Cells market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

NK Cells Market by Company

Affimed NV

Altor BioScience

Chipscreen Biosciences

Fortress Biotech

Henry Ford Health Services

Innate Pharma

NantKwest

NKT

Sorrento Therapeutics

Bristol-Myers Squibb

Takeda

NK Cells Segment by Type

Mogamulizumab

Lorvotuzumab Mertansine

Others

NK Cells Segment by Application

Cancer

Cardiovascular Diseases

Others

NK Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of NK Cells manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of NK Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Mogamulizumab Table 2. Major Company of Lorvotuzumab Mertansine Table 3. Major Company of Others Table 4. Global NK Cells Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global NK Cells Sales by Type (2021-2026) & (g) Table 6. Global NK Cells Sales Market Share in Volume by Type (2021-2026) Table 7. Global NK Cells Sales by Type (2021-2026) & (US$ Million) Table 8. Global NK Cells Sales Market Share in Value by Type (2021-2026) Table 9. Global NK Cells Price by Type (2021-2026) & (US$/g) Table 10. Global NK Cells Sales by Type (2027-2032) & (g) Table 11. Global NK Cells Sales Market Share in Volume by Type (2027-2032) Table 12. Global NK Cells Sales by Type (2027-2032) & (US$ Million) Table 13. Global NK Cells Sales Market Share in Value by Type (2027-2032) Table 14. Global NK Cells Price by Type (2027-2032) & (US$/g) Table 15. North America NK Cells Sales by Type (2021-2026) & (g) Table 16. North America NK Cells Sales by Type (2021-2026) & (US$ Million) Table 17. Europe NK Cells Sales by Type (2021-2026) & (g) Table 18. Europe NK Cells Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific NK Cells Sales by Type (2021-2026) & (g) Table 20. Asia-Pacific NK Cells Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America NK Cells Sales by Type (2021-2026) & (g) Table 22. Latin America NK Cells Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa NK Cells Sales by Type (2021-2026) & (g) Table 24. Middle East and Africa NK Cells Sales by Type (2021-2026) & (US$ Million) Table 25. NK Cells Industry Trends Table 26. NK Cells Industry Drivers Table 27. NK Cells Industry Opportunities and Challenges Table 28. NK Cells Industry Restraints Table 29. Global NK Cells Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global NK Cells Revenue Market Share by Company (2021-2026) Table 31. Global NK Cells Sales by Company (2021-2026) & (g) Table 32. Global NK Cells Sales Share by Company (2021-2026) Table 33. Global NK Cells Market Price by Company (2021-2026) & (US$/g) Table 34. Global NK Cells Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global NK Cells Major Company Production Sites and Headquarters Table 36. Global NK Cells Company, Product Type & Application Table 37. Global NK Cells Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global NK Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global NK Cells Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global NK Cells Sales by Region (2021-2026) & (g) Table 42. Global NK Cells Sales Market Share in Volume by Region (2021-2026) Table 43. Global NK Cells Sales by Region (2021-2026) & (US$ Million) Table 44. Global NK Cells Sales Market Share in Value by Region (2021-2026) Table 45. Global NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 46. Global NK Cells Sales by Region (2027-2032) & (g) Table 47. Global NK Cells Sales Market Share in Volume by Region (2027-2032) Table 48. Global NK Cells Sales by Region (2027-2032) & (US$ Million) Table 49. Global NK Cells Sales Market Share in Value by Region (2027-2032) Table 50. Global NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 51. Global NK Cells Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global NK Cells Sales by Application (2021-2026) & (g) Table 53. Global NK Cells Sales Market Share in Volume by Application (2021-2026) Table 54. Global NK Cells Sales by Application (2021-2026) & (US$ Million) Table 55. Global NK Cells Sales Market Share in Value by Application (2021-2026) Table 56. Global NK Cells Price by Application (2021-2026) & (US$/g) Table 57. Global NK Cells Sales by Application (2027-2032) & (g) Table 58. Global NK Cells Sales Market Share in Volume by Application (2027-2032) Table 59. Global NK Cells Sales by Application (2027-2032) & (US$ Million) Table 60. Global NK Cells Sales Market Share in Value by Application (2027-2032) Table 61. Global NK Cells Price by Application (2027-2032) & (US$/g) Table 62. North America NK Cells Sales by Application (2021-2026) & (g) Table 63. North America NK Cells Sales by Application (2021-2026) & (US$ Million) Table 64. Europe NK Cells Sales by Application (2021-2026) & (g) Table 65. Europe NK Cells Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific NK Cells Sales by Application (2021-2026) & (g) Table 67. Asia-Pacific NK Cells Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America NK Cells Sales by Application (2021-2026) & (g) Table 69. Latin America NK Cells Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa NK Cells Sales by Application (2021-2026) & (g) Table 71. Middle East and Africa NK Cells Sales by Application (2021-2026) & (US$ Million) Table 72. Affimed NV Company Information Table 73. Affimed NV Business Overview Table 74. Affimed NV NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 75. Affimed NV NK Cells Product Portfolio Table 76. Affimed NV Recent Development Table 77. Altor BioScience Company Information Table 78. Altor BioScience Business Overview Table 79. Altor BioScience NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 80. Altor BioScience NK Cells Product Portfolio Table 81. Altor BioScience Recent Development Table 82. Chipscreen Biosciences Company Information Table 83. Chipscreen Biosciences Business Overview Table 84. Chipscreen Biosciences NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 85. Chipscreen Biosciences NK Cells Product Portfolio Table 86. Chipscreen Biosciences Recent Development Table 87. Fortress Biotech Company Information Table 88. Fortress Biotech Business Overview Table 89. Fortress Biotech NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 90. Fortress Biotech NK Cells Product Portfolio Table 91. Fortress Biotech Recent Development Table 92. Henry Ford Health Services Company Information Table 93. Henry Ford Health Services Business Overview Table 94. Henry Ford Health Services NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 95. Henry Ford Health Services NK Cells Product Portfolio Table 96. Henry Ford Health Services Recent Development Table 97. Innate Pharma Company Information Table 98. Innate Pharma Business Overview Table 99. Innate Pharma NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 100. Innate Pharma NK Cells Product Portfolio Table 101. Innate Pharma Recent Development Table 102. NantKwest Company Information Table 103. NantKwest Business Overview Table 104. NantKwest NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 105. NantKwest NK Cells Product Portfolio Table 106. NantKwest Recent Development Table 107. NKT Company Information Table 108. NKT Business Overview Table 109. NKT NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 110. NKT NK Cells Product Portfolio Table 111. NKT Recent Development Table 112. Sorrento Therapeutics Company Information Table 113. Sorrento Therapeutics Business Overview Table 114. Sorrento Therapeutics NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 115. Sorrento Therapeutics NK Cells Product Portfolio Table 116. Sorrento Therapeutics Recent Development Table 117. Bristol-Myers Squibb Company Information Table 118. Bristol-Myers Squibb Business Overview Table 119. Bristol-Myers Squibb NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 120. Bristol-Myers Squibb NK Cells Product Portfolio Table 121. Bristol-Myers Squibb Recent Development Table 122. Takeda Company Information Table 123. Takeda Business Overview Table 124. Takeda NK Cells Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 125. Takeda NK Cells Product Portfolio Table 126. Takeda Recent Development Table 127. North America NK Cells Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 128. North America NK Cells Sales by Country (2021-2026) & (g) Table 129. North America NK Cells Sales Market Share by Country (2021-2026) Table 130. North America NK Cells Sales Forecast by Country (2027-2032) & (g) Table 131. North America NK Cells Sales Market Share Forecast by Country (2027-2032) Table 132. North America NK Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America NK Cells Market Size by Country (2021-2026) & (US$ Million) Table 134. North America NK Cells Market Share by Country (2021-2026) Table 135. North America NK Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America NK Cells Market Share Forecast by Country (2027-2032) Table 137. Europe NK Cells Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 138. Europe NK Cells Sales by Country (2021-2026) & (g) Table 139. Europe NK Cells Sales Market Share by Country (2021-2026) Table 140. Europe NK Cells Sales Forecast by Country (2027-2032) & (g) Table 141. Europe NK Cells Sales Market Share Forecast by Country (2027-2032) Table 142. Europe NK Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe NK Cells Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe NK Cells Market Share by Country (2021-2026) Table 145. Europe NK Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe NK Cells Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific NK Cells Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific NK Cells Sales by Country (2021-2026) & (g) Table 149. Asia-Pacific NK Cells Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific NK Cells Sales Forecast by Country (2027-2032) & (g) Table 151. Asia-Pacific NK Cells Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific NK Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific NK Cells Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific NK Cells Market Share by Country (2021-2026) Table 155. Asia-Pacific NK Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific NK Cells Market Share Forecast by Country (2027-2032) Table 157. Latin America NK Cells Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 158. Latin America NK Cells Sales by Country (2021-2026) & (g) Table 159. Latin America NK Cells Sales Market Share by Country (2021-2026) Table 160. Latin America NK Cells Sales Forecast by Country (2027-2032) & (g) Table 161. Latin America NK Cells Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America NK Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America NK Cells Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America NK Cells Market Share by Country (2021-2026) Table 165. Latin America NK Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America NK Cells Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa NK Cells Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa NK Cells Sales by Country (2021-2026) & (g) Table 169. Middle East and Africa NK Cells Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa NK Cells Sales Forecast by Country (2027-2032) & (g) Table 171. Middle East and Africa NK Cells Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa NK Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa NK Cells Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa NK Cells Market Share by Country (2021-2026) Table 175. Middle East and Africa NK Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa NK Cells Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. NK Cells Distributors List Table 180. NK Cells Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. NK Cells Image Figure 2. Global NK Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NK Cells Market Size (2021-2032) & (US$ Million) Figure 4. Global NK Cells Sales (2021-2032) & (g) Figure 5. Mogamulizumab Image Figure 6. Global Mogamulizumab Sales YoY Growth (2021-2032) & (g) Figure 7. Lorvotuzumab Mertansine Image Figure 8. Global Lorvotuzumab Mertansine Sales YoY Growth (2021-2032) & (g) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (g) Figure 11. Global NK Cells Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global NK Cells Market Share by Type 2025 VS 2032 Figure 13. North America NK Cells Sales Market Share in Volume by Type in 2025 Figure 14. North America NK Cells Sales Market Share in Value by Type in 2025 Figure 15. Europe NK Cells Sales Market Share in Volume by Type in 2025 Figure 16. Europe NK Cells Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific NK Cells Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific NK Cells Sales Market Share in Value by Type in 2025 Figure 19. Latin America NK Cells Sales Market Share in Volume by Type in 2025 Figure 20. Latin America NK Cells Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa NK Cells Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa NK Cells Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 NK Cells Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cancer Image Figure 26. Global Cancer Sales YoY Growth (2021-2032) & (g) Figure 27. Cardiovascular Diseases Image Figure 28. Global Cardiovascular Diseases Sales YoY Growth (2021-2032) & (g) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (g) Figure 31. Global NK Cells Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global NK Cells Market Share by Application 2025 VS 2032 Figure 33. North America NK Cells Sales Market Share in Volume by Application in 2025 Figure 34. North America NK Cells Sales Market Share in Value by Application in 2025 Figure 35. Europe NK Cells Sales Market Share in Volume by Application in 2025 Figure 36. Europe NK Cells Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific NK Cells Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific NK Cells Sales Market Share in Value by Application in 2025 Figure 39. Latin America NK Cells Sales Market Share in Volume by Application in 2025 Figure 40. Latin America NK Cells Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa NK Cells Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa NK Cells Sales Market Share in Value by Application in 2025 Figure 43. North America NK Cells Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 44. North America NK Cells Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America NK Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America NK Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe NK Cells Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 48. Europe NK Cells Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe NK Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe NK Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific NK Cells Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 52. Asia-Pacific NK Cells Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific NK Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific NK Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America NK Cells Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 56. Latin America NK Cells Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America NK Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America NK Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa NK Cells Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 60. Middle East and Africa NK Cells Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa NK Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa NK Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. NK Cells Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. NK Cells Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
Applications
  • Cancer
  • Cardiovascular Diseases
  • Others
Companies covered
  • Affimed NV
  • Altor BioScience
  • Chipscreen Biosciences
  • Fortress Biotech
  • Henry Ford Health Services
  • Innate Pharma
  • NantKwest
  • NKT
  • Sorrento Therapeutics
  • Bristol-Myers Squibb
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NK Cells Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global NK Cells Sales Estimates and Forecasts (2021-2032)
  5. 1.3 NK Cells Market by Type
  6. 1.3.1 Mogamulizumab
  7. 1.3.2 Lorvotuzumab Mertansine
  8. 1.3.3 Others
  9. 1.4 Global NK Cells Market Size by Type
  10. 1.4.1 Global NK Cells Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global NK Cells Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global NK Cells Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America NK Cells Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe NK Cells Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific NK Cells Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America NK Cells Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa NK Cells Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 NK Cells Industry Trends
  2. 2.2 NK Cells Industry Drivers
  3. 2.3 NK Cells Industry Opportunities and Challenges
  4. 2.4 NK Cells Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by NK Cells Revenue (2021-2026)
  2. 3.2 Global Top Players by NK Cells Sales (2021-2026)
  3. 3.3 Global Top Players by NK Cells Price (2021-2026)
  4. 3.4 Global NK Cells Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global NK Cells Major Company Production Sites & Headquarters
  6. 3.6 Global NK Cells Company, Product Type & Application
  7. 3.7 Global NK Cells Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global NK Cells Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 NK Cells Players Market Share by Revenue in 2025
  11. 3.8.3 2025 NK Cells Tier 1, Tier 2, and Tier 3
4 NK Cells Regional Status and Outlook
  1. 4.1 Global NK Cells Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global NK Cells Historic Market Size by Region
  3. 4.2.1 Global NK Cells Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global NK Cells Sales in Value by Region (2021-2026)
  5. 4.2.3 Global NK Cells Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global NK Cells Forecasted Market Size by Region
  7. 4.3.1 Global NK Cells Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global NK Cells Sales in Value by Region (2027-2032)
  9. 4.3.3 Global NK Cells Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 NK Cells by Application
  1. 5.1 NK Cells Market by Application
  2. 5.1.1 Cancer
  3. 5.1.2 Cardiovascular Diseases
  4. 5.1.3 Others
  5. 5.2 Global NK Cells Market Size by Application
  6. 5.2.1 Global NK Cells Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global NK Cells Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global NK Cells Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America NK Cells Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe NK Cells Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific NK Cells Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America NK Cells Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa NK Cells Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Affimed NV
  2. 6.1.1 Affimed NV Company Information
  3. 6.1.2 Affimed NV Business Overview
  4. 6.1.3 Affimed NV NK Cells Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Affimed NV NK Cells Product Portfolio
  6. 6.1.5 Affimed NV Recent Developments
  7. 6.2 Altor BioScience
  8. 6.2.1 Altor BioScience Company Information
  9. 6.2.2 Altor BioScience Business Overview
  10. 6.2.3 Altor BioScience NK Cells Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Altor BioScience NK Cells Product Portfolio
  12. 6.2.5 Altor BioScience Recent Developments
  13. 6.3 Chipscreen Biosciences
  14. 6.3.1 Chipscreen Biosciences Company Information
  15. 6.3.2 Chipscreen Biosciences Business Overview
  16. 6.3.3 Chipscreen Biosciences NK Cells Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chipscreen Biosciences NK Cells Product Portfolio
  18. 6.3.5 Chipscreen Biosciences Recent Developments
  19. 6.4 Fortress Biotech
  20. 6.4.1 Fortress Biotech Company Information
  21. 6.4.2 Fortress Biotech Business Overview
  22. 6.4.3 Fortress Biotech NK Cells Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fortress Biotech NK Cells Product Portfolio
  24. 6.4.5 Fortress Biotech Recent Developments
  25. 6.5 Henry Ford Health Services
  26. 6.5.1 Henry Ford Health Services Company Information
  27. 6.5.2 Henry Ford Health Services Business Overview
  28. 6.5.3 Henry Ford Health Services NK Cells Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Henry Ford Health Services NK Cells Product Portfolio
  30. 6.5.5 Henry Ford Health Services Recent Developments
  31. 6.6 Innate Pharma
  32. 6.6.1 Innate Pharma Company Information
  33. 6.6.2 Innate Pharma Business Overview
  34. 6.6.3 Innate Pharma NK Cells Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Innate Pharma NK Cells Product Portfolio
  36. 6.6.5 Innate Pharma Recent Developments
  37. 6.7 NantKwest
  38. 6.7.1 NantKwest Company Information
  39. 6.7.2 NantKwest Business Overview
  40. 6.7.3 NantKwest NK Cells Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 NantKwest NK Cells Product Portfolio
  42. 6.7.5 NantKwest Recent Developments
  43. 6.8 NKT
  44. 6.8.1 NKT Company Information
  45. 6.8.2 NKT Business Overview
  46. 6.8.3 NKT NK Cells Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 NKT NK Cells Product Portfolio
  48. 6.8.5 NKT Recent Developments
  49. 6.9 Sorrento Therapeutics
  50. 6.9.1 Sorrento Therapeutics Company Information
  51. 6.9.2 Sorrento Therapeutics Business Overview
  52. 6.9.3 Sorrento Therapeutics NK Cells Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sorrento Therapeutics NK Cells Product Portfolio
  54. 6.9.5 Sorrento Therapeutics Recent Developments
  55. 6.10 Bristol-Myers Squibb
  56. 6.10.1 Bristol-Myers Squibb Company Information
  57. 6.10.2 Bristol-Myers Squibb Business Overview
  58. 6.10.3 Bristol-Myers Squibb NK Cells Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bristol-Myers Squibb NK Cells Product Portfolio
  60. 6.10.5 Bristol-Myers Squibb Recent Developments
  61. 6.11 Takeda
  62. 6.11.1 Takeda Company Information
  63. 6.11.2 Takeda Business Overview
  64. 6.11.3 Takeda NK Cells Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Takeda NK Cells Product Portfolio
  66. 6.11.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America NK Cells Sales by Country
  2. 7.1.1 North America NK Cells Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America NK Cells Sales by Country (2021-2026)
  4. 7.1.3 North America NK Cells Sales Forecast by Country (2027-2032)
  5. 7.2 North America NK Cells Market Size by Country
  6. 7.2.1 North America NK Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America NK Cells Market Size by Country (2021-2026)
  8. 7.2.3 North America NK Cells Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe NK Cells Sales by Country
  2. 8.1.1 Europe NK Cells Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe NK Cells Sales by Country (2021-2026)
  4. 8.1.3 Europe NK Cells Sales Forecast by Country (2027-2032)
  5. 8.2 Europe NK Cells Market Size by Country
  6. 8.2.1 Europe NK Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe NK Cells Market Size by Country (2021-2026)
  8. 8.2.3 Europe NK Cells Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific NK Cells Sales by Country
  2. 9.1.1 Asia-Pacific NK Cells Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific NK Cells Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific NK Cells Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific NK Cells Market Size by Country
  6. 9.2.1 Asia-Pacific NK Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific NK Cells Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific NK Cells Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America NK Cells Sales by Country
  2. 10.1.1 South America NK Cells Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America NK Cells Sales by Country (2021-2026)
  4. 10.1.3 South America NK Cells Sales Forecast by Country (2027-2032)
  5. 10.2 South America NK Cells Market Size by Country
  6. 10.2.1 South America NK Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America NK Cells Market Size by Country (2021-2026)
  8. 10.2.3 South America NK Cells Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa NK Cells Sales by Country
  2. 11.1.1 Middle East and Africa NK Cells Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa NK Cells Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa NK Cells Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa NK Cells Market Size by Country
  6. 11.2.1 Middle East and Africa NK Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa NK Cells Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa NK Cells Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 NK Cells Value Chain Analysis
  2. 12.1.1 NK Cells Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 NK Cells Production Mode & Process
  7. 12.2 NK Cells Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 NK Cells Distributors
  10. 12.2.3 NK Cells Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst